Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesBeginning Cash BalanceBeginning Cash BalanceCash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based Compensation
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATGross ProfitLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares OutstandingShares Outstanding
Ratios

BioCorRx (BICX) Shares Issued (2010 - 2023)

BioCorRx recorded quarterly Shares Issued of $600000.0 in Q2 2023, up 100.0% quarter-over-quarter from $300000.0 in Q1 2023, and up 140.0% year-over-year from $250000.0 in Q2 2022.

BioCorRx's Shares Issued history runs 7 years deep, the most recent figure standing at $600000.0 for Q2 2023.

  • In Q2 2023, Shares Issued rose 140.0% year-over-year to $600000.0; the TTM figure through Mar 2024 stood at $900000.0 (up 63.64% YoY), while the FY2022 annual figure was $1.2 million, down 44.44% from the prior year.
  • Shares Issued came in at $600000.0 for Q2 2023 at BioCorRx, up from $300000.0 in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $2.2 million in Q1 2021 to a low of $100000.0 in Q1 2019.
  • A 4-year average of $750000.0 and a median of $450000.0 in 2023 frame the typical range for Shares Issued.
  • On a YoY basis, Shares Issued climbed as much as 140.0% in 2023 and fell as far as 70.0% in 2023.
  • BioCorRx's Shares Issued stood at $100000.0 in 2019, then surged by 2150.0% to $2.2 million in 2021, then tumbled by 88.89% to $250000.0 in 2022, then soared by 140.0% to $600000.0 in 2023.
  • According to Business Quant data, Shares Issued over the past three periods registered $600000.0, $300000.0, and $250000.0 for Q2 2023, Q1 2023, and Q2 2022 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Issued (Qtr)
1 HCA Healthcare 84.64 Bn 87.02 Bn 16.26 Bn -
2 Tenet Healthcare 15.22 Bn 14.39 Bn 4.41 Bn -
3 Davita 13.10 Bn 13.96 Bn 1.07 Bn 2.39 Mn
4 Encompass Health 10.50 Bn 11.12 Bn 1.34 Bn -
5 Ensign 9.69 Bn 9.09 Bn 293.37 Mn 11.49 Mn
6 Universal Health Services 8.92 Bn 8.88 Bn 3.21 Bn 3.78 Mn
7 Fresenius Medical Care AG 7.31 Bn 4.93 Bn 22,843.10 Bn -
8 Chemed 5.83 Bn 5.81 Bn 215.76 Mn 1.31 Mn
9 Pacs 5.76 Bn 5.51 Bn 345.96 Mn -
10 BioCorRx - - 189,355.00 -

Historic Data

Download Data 🔒
DateValue
Jun 30, 2023 600,000.00
Jun 30, 2023 600,000.00
Mar 31, 2023 300,000.00
Mar 31, 2023 300,000.00
Jun 30, 2022 250,000.00
Jun 30, 2022 250,000.00
Mar 31, 2022 1.00 Mn
Mar 31, 2022 1.00 Mn
Mar 31, 2021 2.25 Mn
Mar 31, 2021 2.25 Mn
Mar 31, 2019 100,000.00
Mar 31, 2019 100,000.00
Dec 31, 2018 100,000.00
Dec 31, 2018 100,000.00
Jun 30, 2018 100,000.00
Jun 30, 2018 100,000.00
Mar 31, 2018 150,000.00
Mar 31, 2018 150,000.00
Mar 31, 2017 940,000.00
Mar 31, 2017 940,000.00
Dec 31, 2010 -84,000.00
Dec 31, 2010 -84,000.00